Showing results (731-740 of 739) with videos related to
Sort By:
Pageof 74
You have reached the last page of results.This site can display upto 739 results.
The Lancet. Haematology|February 3, 2022
Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working GroupNoopur S Raje, Elias Anaissie, Shaji K Kumar, et al.Acta Pharmacologica Sinica|July 27, 2022
A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture riskHao Zhang, Jie-Mei Gu, Ai-Jun Chao, et al.Hepatology (Baltimore, Md.)|March 25, 2015
Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis BDe-Ke Jiang, Xiao-Pin Ma, Hongjie Yu, et al.Signal Transduction and Targeted Therapy|December 5, 2020
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cellsKe Wang, Wei Chen, Zheng Zhang, et al.Signal Transduction and Targeted Therapy|January 30, 2023
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trialHuijie Bian, Liang Chen, Zhao-Hui Zheng, et al.Nature Cell Biology|February 29, 2024
A guideline on the molecular ecosystem regulating ferroptosisEnyong Dai, Xin Chen, Andreas Linkermann, et al.Signal Transduction and Targeted Therapy|April 13, 2025
Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trialHuijie Bian, Liang Chen, Zheng Zhang, et al.Signal Transduction and Targeted Therapy|May 18, 2021
Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trialHuijie Bian, Zhao-Hui Zheng, Ding Wei, et al.Nature Genetics|December 18, 2012
Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinomaDe-Ke Jiang, Jielin Sun, Guangwen Cao, et al.Pageof 74